Clinical Roundup Xtandi + leuprolide improves OS in non-metastatic hormone-sensitive prostate cancer with high-risk biochemical recurrence, phase III data show July 11, 2025Vol.51 No.27
Clinical Roundup Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds July 11, 2025Vol.51 No.27
Clinical Roundup Neoadjuvant ablative radiotherapy + chemo reduces risk of pancreatic cancer regrowth, stimulates immune system, cohort study finds July 11, 2025Vol.51 No.27
Clinical Roundup Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows July 11, 2025Vol.51 No.27
Clinical Roundup Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA preclinical study finds July 11, 2025Vol.51 No.27
Clinical Roundup AI could help pathologists match cancer patients to the right treatments faster and more efficiently, study shows July 11, 2025Vol.51 No.27
Clinical Roundup PARP1 inhibitors halt EBV-driven lymphoma by disrupting a key cancer pathway, preclinical study finds July 11, 2025Vol.51 No.27
Clinical Roundup “Power surges” on cancer cell membranes may fuel progression of disease, Johns Hopkins study finds July 11, 2025Vol.51 No.27
Clinical Roundup UCLA study identifies key protein that helps liver cancer resist heat-based treatment July 11, 2025Vol.51 No.27
Clinical Roundup Cardiac biomarkers linked to future cancer risk, even without heart disease, says UCLA prospective cohort study July 11, 2025Vol.51 No.27
